How coffee compounds may protect the body ^{CEFR B1}

For decades, studies have associated coffee drinking with longer life and lower risk of chronic disease. New work from Texas A&M University’s College of Veterinary Medicine and Biomedical Sciences, published in Nutrients, offers a possible mechanism. The researchers highlight NR4A1, a nuclear receptor that helps regulate gene activity when tissues are stressed or damaged. Stephen Safe and colleagues describe NR4A1 as a nutrient sensor that reduces damage in many tissues.

The team tested multiple compounds found in coffee and found that several—especially polyhydroxy and polyphenolic compounds like caffeic acid—bind to NR4A1 and modify its activity. In laboratory models these compounds reduced cellular damage and slowed cancer cell growth in ways consistent with protection. When researchers removed NR4A1 from cells, the protective effects disappeared. Although caffeine binds the receptor, it produced little effect in the models, which may help explain similar findings for regular and decaffeinated coffee in population studies.

Safe notes the study is mechanistic and does not prove direct cause-and-effect in people. The researchers are now exploring synthetic compounds that target NR4A1 more effectively, aiming to develop treatments for cancer and other diseases.